CME Group Inc. (NASDAQ:CME) Shares Bought by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. raised its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,041,526 shares of the financial services provider’s stock after acquiring an additional 23,340 shares during the quarter. Raymond James Financial Services Advisors Inc. owned approximately 0.29% of CME Group worth $224,230,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. AE Wealth Management LLC grew its stake in CME Group by 25.5% during the 3rd quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock valued at $509,000 after acquiring an additional 516 shares in the last quarter. Oak Thistle LLC purchased a new stake in shares of CME Group in the third quarter valued at approximately $462,000. Ropes Wealth Advisors LLC acquired a new stake in shares of CME Group in the third quarter valued at approximately $231,000. U.S. Capital Wealth Advisors LLC lifted its position in CME Group by 12.3% during the third quarter. U.S. Capital Wealth Advisors LLC now owns 1,651 shares of the financial services provider’s stock worth $331,000 after buying an additional 181 shares in the last quarter. Finally, Brookstone Capital Management grew its holdings in CME Group by 15.6% in the 3rd quarter. Brookstone Capital Management now owns 25,807 shares of the financial services provider’s stock valued at $5,526,000 after buying an additional 3,474 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a report on Thursday, April 25th. Barclays raised their target price on CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 25th. Bank of America upped their price target on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Argus raised their price objective on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research report on Thursday, April 25th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $217.80.

Read Our Latest Research Report on CME Group

CME Group Stock Up 0.0 %

CME Group stock traded up $0.02 during midday trading on Tuesday, reaching $209.64. The company’s stock had a trading volume of 1,394,434 shares, compared to its average volume of 1,778,121. The company has a market cap of $75.47 billion, a P/E ratio of 23.85, a P/E/G ratio of 5.27 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The business has a 50-day simple moving average of $214.65 and a 200-day simple moving average of $211.69. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm’s revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $2.42 earnings per share. On average, research analysts expect that CME Group Inc. will post 9.72 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were given a dividend of $1.15 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.19%. CME Group’s payout ratio is 52.33%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.